EGI
VCYT icon

EAM Global Investors’s Veracyte VCYT Stock Holding History

EAM Global Investors’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-52,273
Closed -$1.25M – 148
2019
Q3 		$1.25M Sell
52,273
-46,310
-47% -$1.23M 0.61% 86
2019
Q2 		$2.81M Sell
98,583
-25,149
-20% -$628K 1.2% 11
2019
Q1 		$3.1M Hold
123,732
– – 1.37% 13
2018
Q4 		$1.56M Buy
123,732
+28,832
+30% +$341K 0.85% 41
2018
Q3 		$906K Buy
+94,900
New +$1.05M 0.37% 142

Other funds holding VCYT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

EAM Global Investors's VCYT Position: Q4 2019 in Review

EAM Global Investors sold out of Veracyte (VCYT) in Q4 2019, closing a stake of 52,273 shares — an estimated $1.25M sold.

EAM Global Investors first reported a position in VCYT in Q3 2018 and held it in 5 quarters. The position peaked at $3.1M in Q1 2019. 179 funds tracked by Wall St. Rank hold VCYT as of Q4 2019.

  • EAM Global Investors reported no remaining Veracyte position as of Q4 2019 after selling out during the quarter.
  • EAM Global Investors sold 52,273 Veracyte shares in Q4 2019, an estimated $1.25M.
  • EAM Global Investors first reported a position in Veracyte in Q3 2018 and held it in 5 quarters.
  • EAM Global Investors's Veracyte position peaked at $3.1M in Q1 2019.
  • 179 funds tracked by Wall St. Rank held Veracyte as of Q4 2019.

Based on EAM Global Investors's 13F filing for Q4 2019, filed 10 Feb 2020.